Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

More promising cancer news from AACR-NCI-EORTC: Hughes Institute presents new compounds

Nov. 24, 1999

Radicicol derivative KF-58333 is a promising antileukemia agent

Nov. 24, 1999

European screening program identifies novel anticancer drug candidate

Nov. 24, 1999

Bayer presents novel camptothecin glycoconjugates at AACR-NCI-EORTC meeting

Nov. 24, 1999

VEGF receptor tyrosine kinase inhibitor PTK-787 is a potent antiangiogenic agent

Nov. 24, 1999

U.S. academic team takes a novel approach to treating prostate cancer

Nov. 24, 1999

New taxane analogue from Bristol-Myers Squibb now in phase I testing

Nov. 24, 1999

Combination A6 and tamoxifen effective in rat breast tumor

Nov. 24, 1999

SuperGen and Stehlin Foundation extend research and licensing agreement

Nov. 24, 1999

New SERM from SRI and Taiho holds excellent clinical potential

Nov. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...